ArticleIntestinal research2026

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Antonio Tursi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.